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Abstract
Background: Head and neck cancer is often managed with a combination of surgery, radiation therapy, and
chemotherapy, and skin toxicity is not uncommon. Xanthogranuloma is a pathological finding resulting from an
inflammatory reaction that has not been previously reported following head and neck radiation therapy.
Case presentation: A patient with squamous cell carcinoma of the oropharynx, treated with definitive
chemoradiation and hyperthermia, presented at eight-month follow-up with an in-field cutaneous lesion in the low
neck, initially concerning for recurrent tumor.
Biopsy showed xanthogranuloma and the patient underwent complete resection with congruent surgical
pathology. The patient remained free of malignancy but continued to experience wound healing difficulties at the
resection site which resolved with specialized wound care and hyperbaric oxygen.
Conclusions: Skin toxicity is not uncommon in patients with head and neck cancer treated with radiation therapy.
Awareness of unusual pathologic sequelae, such as xanthogranuloma, is needed to provide patient counseling
while continuing appropriate surveillance for recurrent malignancy.
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Background
For patients with locally advanced head and neck cancer,
the use of radiation therapy with concurrent chemother-
apy is supported by multiple randomized trials [1]. This
treatment can produce both acute and late toxicity
to normal tissues [2]. Known late toxicities to the
skin include permanent skin tanning, telangiectasias,
necrosis, and fibrosis.
We report a case of a patient with head and neck can-
cer treated with radiation therapy who later presented
with xanthogranuloma arising within the radiation field.
Xanthogranuloma is a histopathological diagnosis, refer-
ring to a lesion comprised of abundant histiocytes, often
displaying foamy cytoplasm and associated foreign body
giant cells [3]. Juvenile xanthogranulomatosis (JXG) is a
clinical diagnosis first described in the 1950s, referring
to children with one or more of these lesions [4]. JXG is
thought to be a benign disorder, although ocular involve-
ment may impact 0.5 % of patients with skin involve-
ment [4]. Xanthogranulomas have been described in
adults in association with multiple possible risk fac-
tors, including trauma, infection, and malignancy.
Xanthogranuloma has been reported in a patient
treated with radiation therapy for breast cancer, but it
has not been previously reported in the English litera-
ture following head and neck irradiation [5]. To in-
crease awareness of this potential late effect of
chemoradiation, we present the case and review rele-
vant related literature.
Case presentation
At the age of 45, a patient with a 30-pack year his-
tory of tobacco use and no significant past medical
history presented to our institution with pathology-proven
AJCC Stage IVA, T3 (lingual epiglottis extension), N2c
(bilateral lymph node involvement), M0 squamous cell
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carcinoma of the left base of tongue. Notably, he had
history of a palpable left upper neck mass three years
prior, but fine needle aspiration (FNA) at that time
was non-diagnostic. The neck mass recurred and he
initially pursued treatment with homeopathic therapy.
The mass increased in size, leading him to seek further
medical attention and ultrasound showed a very large left
supraclavicular mass and a right submandibular mass.
FNA of the left neck mass showed p16-overexpressing
squamous cell carcinoma. Positron emission tomography
with computed tomography (PET/CT) showed a mass
involving the left tonsillar pillar and extending to the piri-
form sinus, with increased avidity on FDG-PET and meas-
uring over 3 cm in longest diameter. He was also noted to
have FDG-avid suspicious lymph nodes involving the right
level IIA, left level IIA and left level IV. A left parapharyn-
geal lymph node was also concerning. At the time of the
initial radiation oncology consult he endorsed weight loss,
left neck pain, dysgeusia, decreased appetite, and tracheal
pressure without shortness of breath. He had received no
treatment for the left oropharyngeal cancer except for
treatment with hyperthermia in ten fractions at an outside
facility.
On exam, he was found to have Karnofsky Perform-
ance Status of 80, vital signs within normal limits,
and a greater than 6 cm left-sided lymph node con-
glomerate and palpable left level II lymph node and
right level II/III lymph nodes, with slight tracheal de-
viation to right. Concurrent cisplatin-based chemora-
diation was advised and the patient consented to
treatment.
Treatment
The patient was treated at our institution with intensity-
modulated radiation therapy, 70.88 Gy in 34 fractions,
prescribed to the 88 % isodose line, targeting the left
oropharynx and bilateral neck with 6 MV photons, with
concurrent hyperthermia given twice a week to the
massive nodal mass as well as cisplatin.
His treatment course was complicated by intractable
nausea and vomiting following the first cycle of cisplatin.
Due to these symptoms, as well as purulent drainage
from the left neck mass following radiation, he was hos-
pitalized. There was no evidence of infection identified
during hospitalization but there was a golf-ball-sized
area of skin rupture in the left low neck emitting pus
and drainage that was attributed to tumor necrosis. His
chemotherapy was switched to weekly administration.
Over the course of treatment, he also developed grade 2
oral mucositis and dry desquamation of other parts of the
skin. Due to a clinically evident decrease in tumor size, a re-
peat radiation planning CT was obtained and a new radi-
ation plan was generated for use during the last ten
fractions. The patient did not require a feeding tube during
treatment, although for the month following completion
of radiation therapy, he elected to receive frequent intra-
venous hydration.
Post-treatment surveillance
At the six month follow-up appointment, magnetic res-
onance imaging (MRI) of the head and neck showed
treatment response of the primary tumor and bilateral
neck. On interval physical exam, he had residual right
level II lymphadenopathy and stiffness in the left neck
with erythematous and hypo-pigmented areas. There
were no palpable base of tongue lesions. At 3 month
follow-up, PET/CT showed that the right level II lymph
node was not FDG-avid. At repeat MRI two months
later, the right level II lymph node was stable and the pa-
tient appeared to have no evidence of disease although
on exam, telangiectasias were noted in the skin at the
left supraclavicular region.
At follow-up eight months after completion of chemo-
radiation, he was found to have a 1.5x1.5 cm irregularly
shaped, reddish-purplish-colored lesion extruding out
from the skin in level IV of the left neck, with surround-
ing deep red ecchymosis. This new mass was located in
the area of the rupture through skin. MRI at that time
showed small left level 3, 5a, and 5b lymphadenopathy
underlying the area. The cutaneous left neck lesion was
concerning for cancer recurrence and he was referred
for biopsy. The lesion is shown in Fig. 1.
Cytopathology
FNA with three passes was performed. Aspirate material
was abundantly cellular and composed of numerous
foamy histiocytes and a sparse inflammatory infiltrate
within a background of lipid debris. No epithelial cells
were noted on aspirate smears or cell block material.
Additionally, a pankeratin immunohistochemical stain
was performed and was negative, further arguing against
an epithelial component.
CT of the chest was also obtained, which revealed no
metastases. The patient was referred to otolaryngology-
head and neck surgery for management of the left neck
lympadenopathy. Flexible fiberoptic nasopharyngolaryn-
goscopy was normal. A left level IV lesion was again vis-
ible and palpable on exam, with surrounding skin intact
but with associated erythema. Punch biopsy of the cuta-
neous lesion was performed showing dystrophic xantho-
matosis and resection was advised. MRI was re-reviewed
and it was determined that there was no clear sign of
cancer persistence or recurrence within the deep neck.
Resection of xanthogranuloma
At nine months following completion of chemoradiation,
the patient elected for gross resection of the left neck
mass. The mass was over 4 cm in size, and transfer of
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adjacent skin that had not been radiated was required to
close the defect.
Surgical pathology
Gross examination revealed a yellow, firm, oval subcutane-
ous mass measuring 2.1 x 1.6 x 1.0 cm. Histologic sections
revealed a dense population of foamy histiocytes (xanthoma
cells), occasional multinucleate giant cells and scattered in-
terspersed lymphocytes (Figs. 2 and 3) involving the deep
dermis and superficial subcutis. In some areas, these cells
were found to surround degenerating collagen and nuclear
debris (Fig. 4). No obvious epithelial cells or carcinoma
were identified on H&E sections and a keratin immuno-
stain was negative, further arguing against a component of
metastatic carcinoma. The foamy cells were positive for
CD68, supporting a histiocyte lineage (Fig. 5). Histochem-
ical stains were negative for acid-fast and fungal microor-
ganisms, arguing against an infectious component. Lack
of immunostaining for S100-protein and SOX10 argued
against the possibility of melanoma. Overall, the find-
ings were consistent with dystrophic xanthomatosis
(also known as dystrophic xanthogranulomatosis).
Surveillance
MRI seven weeks after resection showed no evidence of
disease. Due to the patient’s history of lymphocytopenia
pre-dating initiation of chemotherapy and possible associ-
ation between the development of xanthogranulomas and
hematological malignancy, the patient was re-evaluated by
the hematology service [6]. The prior low lymphocyte
count was thought to be spurious and no evidence for a
lymphoproliferative disorder was identified. At three
months following the resection, the patient was found to
Fig. 2 Histologic section showing dense population of foamy
histiocytes (xanthoma cells), occasional multinucleate giant cells, and
scattered interspersed lymphocytes involving the deep dermis
and subcutis
Fig. 3 Histologic section showing foamy histiocytes, multinucleate
giant cells, and interspersed lymphocytes
Fig. 1 Left low neck lesion in patient treated with chemoradiation
for head and neck cancer
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have mild erythema of the left neck with an open lesion at
the post-operative site (Fig. 6). Medical grade honey and
foam dressing were prescribed, with continued follow-up
to monitor wound healing. At 14 months from chemora-
diotherapy completion and 6 months from lesion excision,
the patient had no sign of cancer recurrence but contin-
ued to experience wound healing difficulties. It was de-
cided to administer a month of hyperbaric oxygen
treatments and collagenase dressings. By the next fol-
lowup 3 months later, the skin had finally closed, leaving
residual fibrosis and telangiectasia (Fig. 7).
Conclusions
At eight months following completion of chemoradiation
for a locoregionally advanced head and neck cancer, a pa-
tient was to found to develop a xanthogranuloma within
the radiation field. The xanthogranuloma arose in a loca-
tion where the skin had ruptured over a large nodal mass
during the course of treatment. This represents a late radi-
ation toxicity that has not yet been reported in the English
literature in a patient with head and neck cancer. Assess-
ment of patient and treatment-related factors may im-
prove understanding of this toxicity.
A recent consensus report discussed factors contribut-
ing to skin toxicity in patients with head and neck
cancer treated with chemoradiation [7]. Host factors
contributing to toxicity include nutritional status, sun
exposure, and smoking, as well as comorbidities such as
lupus, diabetes, or hypertension. While this patient did
not have known comorbidities, he did have a history of
smoking. His nutritional status was reasonably main-
tained during treatment. Treatment-related factors cited
in the consensus report included skin dose and fraction
size >2 Gy per fraction, as well as the use of bolus and
Fig. 4 Histologic section showing degenerating collagen and
nuclear debris
Fig. 5 Histochemical staining of CD68 in foamy cells, supporting a
histiocyte lineage.
Fig. 6 Left low neck with nonhealing wound after resection
of xanthogranuloma
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radio-sensitizing therapies. Due to the extensive nodal
disease in the low left neck, the skin dose was high and
this increased the risk for toxicity. This patient was also
treated with two radio-sensitizing therapies in the area:
cisplatin and hyperthermia.
Prior studies on the use of radiation, chemotherapy,
and hyperthermia in patients with head and neck
cancer have not identified the skin toxicity that we
describe in this case report. In a study of 40 patients
followed for a median of 9 months, two Grade 1
burns were identified [8]. In a retrospective study of
radiation with or without hyperthermia, acute toxicity
was similar and late toxicity was higher in the com-
bined treatment group, with two patients diagnosed
with bone necrosis [9]. A Phase I-II study on the use
of concurrent cisplatin, hyperthermia and radiation
[10] showed that acute skin toxicity was slightly
higher with the use of hyperthermia than without
(dry desquamation in >50 % of skin surface area vs <50 %
in the areas not treated with hyperthermia). Late effects
were similar with and without hyperthermia, although one
case of RTOG/EORTC grade 4 subcutaneous necrosis was
identified within the hyperthermia field. In a single-
institution study randomizing patients with superficial
tumors to radiation with or without hyperthermia, the
incidence of thermal burns was increased with hyper-
thermia [11]. In summary, this information suggests
that the radio-sensitizing effects of hyperthermia may
put patients at higher risk for toxicity and should be
monitored carefully.
Xanthogranuloma has been reported in a patient re-
ceiving breast radiation [5]. In this case report, the lesion
was identified 12 months following completion of breast
radiation therapy. The authors speculated that due to
the time course, radiation likely played a role. Unlike the
xanthogranuloma in our patient, this lesion was 4 mm
in maximum diameter and was able to be excised with
punch biopsy. Both the breast cancer patient and our
patient received radiation therapy and chemotherapy, al-
though, as per standard of care, the treatments were not
concurrent in the breast cancer patient. Our patient, like
the breast cancer patient, presented with xanthogranu-
loma as a delayed late effect. However, in our patient,
the tumor rupture through the skin during treatment
likely contributed to chronically impaired integrity of the
tissues in that region with a much more exuberant pres-
entation of xanthogranuloma. We hypothesize that the
necrosis and pus ignited a chronic inflammatory re-
sponse arising preferentially in that location, releasing a
macrophage flood that enabled development of
xanthogranuloma.
While patients in the literature have been treated with
chemoradiation and hyperthermia for head and neck can-
cer and have not developed xanthogranuloma, our patient
is unique in that he received neoadjuvant hyperthermia at
an outside facility prior to initiating definitive treatment at
our institution. It is possible that the xanthogranuloma de-
velopment was encouraged in part due to an interaction
between this patient’s immune response and the intensive
radio-sensitization resulting from concurrent cisplatin and
localized hyperthemia. In any case, awareness of acute and
late skin toxicities, including xanthogranuloma, can help
direct the workup, which can be confusing given the over-
riding concern for malignant recurrence.
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Fig. 7 Resolution of left low neck wound after
xanthogranuloma resection
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